Entry into a Material Definitive Agreement

Business Context and Reporting Period

This Form 8-K is filed by American Realty Capital Healthcare Trust II, Inc. (the "Company") on March 13, 2013, reporting events occurring on March 10, 2013. The Company is a real estate investment trust indirectly sponsored by AR Capital, LLC ("ARC"). The filing addresses a material amendment to the Company's advisory agreement and the appointment of new directors.

Key Financial Metrics

The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to the amendment of the advisory agreement and director compensation:

  • Expense Reimbursement Cap: The Company may now reimburse its advisor for organization and offering expenses up to 2.0% of gross proceeds from primary public offerings of common stock, increased from a previous limit of 1.5%.
  • Director Compensation: The newly appointed Lead Independent Director will receive an annual retainer of $55,000 in addition to the standard independent director retainer of $30,000.
  • Equity Awards: The Lead Independent Director is entitled to an award of 1,333 restricted shares of common stock upon appointment and at each annual stockholder's meeting.

Material Changes Versus Prior Period

The filing details two primary material changes effective March 10-13, 2013:

  • Advisory Agreement Amendment: The Company amended its advisory agreement to increase the cap on reimbursable organization and offering expenses from 1.5% to 2.0% of gross proceeds. This change was made to address increasing third-party due diligence and offering costs.
  • Board Composition: The Board appointed William M. Kahane and David Gong as directors. Mr. Gong was further appointed as the Lead Independent Director and Audit Committee Financial Expert.

Guidance, Outlook, and Risks

Management Commentary: Management stated that the amendment to the advisory agreement was necessary due to rising costs associated with due diligence and offerings. Regarding the board appointments, management believes that a majority of independent, experienced directors, including a designated lead independent director, provides the optimal leadership structure for the Company and its stockholders.

Risks and Contingencies: The filing notes that the description of the advisory agreement amendment is a summary and is qualified in its entirety by the full terms of the amendment, which will be filed in the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2013. No specific financial risks or contingencies regarding operations were disclosed in this report.

Important Facts for Investor Verification

  • Verify the full text of the advisory agreement amendment in the upcoming Form 10-Q to understand all terms beyond the 2.0% expense cap increase.
  • Confirm the impact of the increased expense reimbursement cap on future net proceeds from capital raises.
  • Review the background of the new directors, particularly William M. Kahane, who is a principal of ARC (the indirect sponsor), to assess potential related-party transaction implications.
  • Note that the filing does not contain operational financial results; investors should refer to the most recent Form 10-Q or 10-K for financial performance data.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.